Greater Philadelphia – Regional Life Sciences Roundup – October 22, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
The most interesting moves in Greater Philadelphia this week came from companies changing where they aim. Instead of hitting the usual target harder, they looked for a better place to point their science: at the body’s own cells instead of the virus, at a single tissue instead of the whole immune system, at the part of the world where a disease is most common, and at patients who could benefit from a treatment sooner. It’s a quieter kind of ambition, and it shows up across the send.
A Radnor biotech dosed the first patient in a type 1 diabetes trial designed to calm the immune attack only where it’s happening, preserving the body’s own insulin production without switching off the immune system everywhere. A Philadelphia cell therapy company is bringing new data to a major international cancer meeting that takes its treatment beyond the disease it’s approved for, including an early look at using it sooner. Two international partners are bringing isotope production to the Philadelphia suburbs so a scarce isotope being studied for cancer treatment can be made close to the patients and clinical teams who need it.
The same thinking showed up in deals and recognition. A Malvern gene therapy company signed a licensing deal that could take its vision-loss treatment to the region where the inherited eye disease it targets is far more common. Lillian Chiang, founder and CEO of Doylestown’s Evrys Bio, received a biotech impact award from the Pennsylvania Biotechnology Center for an antiviral approach that targets the body’s own cells instead of the virus itself.
Financial
Tracking the capital moving through Greater Philadelphia— funding rounds, M&A activity, and investment trends shaping Philadelphia, Southern New Jersey, and Delaware’s life sciences companies.
Where New Jersey Is Placing Its Venture Bets, and Why Health Leads the List
A state-backed venture program has announced its latest round of investments, and most of the companies that made the cut are in health care and life sciences. They range from medical devices and biotech to AI-driven care coordination, and a couple call South Jersey home. Here’s who’s getting the backing and what it says about how the state is trying to grow its startup scene. Read More >
A Hospital Genomics Lab’s Spinout Just Got a Big Vote of Confidence From Investors
A Philadelphia biotech that grew out of a children’s hospital genomics lab has closed a new round of funding after strong investor demand. The company turns discoveries from human genetics into potential treatments for diseases with few options, and the new money is meant to move its lead programs closer to the clinic. Here’s what the financing will support and who’s backing it. Read More >
A Licensing Deal Built on One Question: Where Is the Need Greatest?
A Malvern gene therapy company has signed a licensing deal that could one day carry its investigational vision-loss treatment well beyond the U.S. The partner will hold the rights in a region where the company says the inherited eye disease it targets is far more common. Here’s what the agreement covers and what still needs to happen before the treatment could reach patients. Read More >
A Six-Year Legal Battle Over Who Gets to Make the Medicine Has a Ruling
A Pennsylvania biotech has won a court judgment in a six-year legal fight with a former manufacturing partner. The dispute centered on whether the partner honored promises tied to transferring the technology needed to make its medicines at scale. Here’s what the court decided and why the company says getting paid may be a separate challenge. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Impact, Recognized: The Founder Behind a Different Kind of Antiviral
Lillian Chiang, founder and CEO of Doylestown’s Evrys Bio, has received a biotech impact award from the Pennsylvania Biotechnology Center at its regional conference. Her company is taking a different route to fighting viral infections, with an approach that targets the body’s own cells instead of the virus itself, according to the company. Read More >
A Radnor Company Adds Launch Experience Before a Big FDA Date
Kristine Peterson and Lonnel Coats have joined the board of Radnor-based Mineralys Therapeutics, adding two veteran pharma leaders with deep experience in commercial launches. The appointments come ahead of an FDA decision date for the company’s lead drug candidate, a once-daily pill being studied for hard-to-control high blood pressure. Here’s what each brings to the table and why the timing matters. Read More >
From Global Industrial Giants to Healthcare Packaging: A New CEO Steps In
Brian Kesseler has been named CEO of Wayne-based TekniPlex, a materials science company that makes critical components and packaging for pharmaceuticals, medical devices, and drug delivery. He arrives from the world of global industrial manufacturing, where he spent more than three decades leading large, complex operations. Here’s a look at his background and what the company’s investors say they’re hoping he’ll accelerate. Read More >
Why a Life Sciences Communicator Is Joining a Mission Beyond the Industry
Gwendolyn Fisher, co-founder and Managing Director of FisherTrent Communications, has joined the Board of Advisors of Life Science Cares Philadelphia, the industry-backed group working to reduce the effects of poverty in the region. She brings a career in life sciences communications and a personal connection to the group’s work, especially its paid internship program for first-generation college students. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Philadelphia, New Jersey, and Delaware life sciences and biotech employers.
The Question Every Life Sciences Founder Should Be Asking
A Philadelphia nonprofit is opening applications for a new program that asks early-stage founders a question many have never considered: how does your technology work in, or for, women? The program is free, doesn’t take equity, and isn’t limited to companies focused on women’s health. Here’s who can apply and what participating startups can expect. Read More >
Working on the Next Big Countermeasure? This Program Wants to Fund Your Next Six Months
A biodefense-focused accelerator is offering non-dilutive funding to early-stage companies and academic teams working on certain countermeasures to health threats. Awards support short, milestone-based projects, with hands-on mentoring and access to government subject matter experts. Applications are closing soon, so here’s what kinds of technologies it’s looking for and who should think about applying. Read More >
Not Sure What a Biopharma Career Looks Like? This Program Shows You, Expenses Paid
A weeklong, all-expenses-paid program is opening applications for college students who are just starting to explore careers in biopharmaceutical manufacturing. Participants get hands-on activities, facility tours, and time with industry professionals, with no cost to them. Here’s who’s eligible and how to apply. Read More >
Who’s hiring?!
Top feature employer (linked), a couple of lines on who they are, their goals, how they view talent/hiring/ no. of open roles (specific region), followed by CTA
Other employers and available roles we’re paying attention to this week:
Top Employer
A global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, Minaris Advanced Therapies is dedicated to helping innovators succeed, from early-stage development through commercial launch , with end-to-end expertise in GMP manufacturing, biosafety, and analytical testing of biologics.
With a state-of-the-art manufacturing facility in the Greater Philadelphia region, Minaris is strengthening one of the world’s leading cell and gene therapy hubs by bringing together scientists, engineers, quality experts, and problem solvers dedicated to helping life-changing therapies reach patients faster and more reliably.
They are currently hiring across 90+ roles in the Greater Philadelphia region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- WuXi AppTec (Middletown, DE) is hiring a Technical Service Engineer – OSD Equipment | Apply Now >
- Johnson & Johnson (West Chester, PA) is hiring an Associate Clinical Designer, Orthopedics | Apply Now >
- Incyte (Wilmington, DE) is hiring a Senior Biostatistical Programming | Apply Now >
- ICON Plc (Bluebell, PA) is hiring a Senior Clinical Research Associate | Apply Now >
- Cabaletta Bio (Philadelphia, PA) is hiring an Associate Director, Program Management- Clinical, Medical, & Regulatory | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across Greater Philadelphia.
A Philadelphia-Area Site Is About to Make Something Cancer Researchers Have Struggled to Get
Two international partners are bringing a specialized piece of equipment to the Philadelphia suburbs, with the aim of making a rare isotope that’s being studied for cancer treatment. The companies say limited supply has held back wider use of the isotope, and producing it close to patients and clinical teams could help change that. Here’s what the collaboration plans to build in the region and who else could benefit. Read More >
What Happens When a Cell Therapy Moves Past the Cancer It Was Approved For?
A Philadelphia cell therapy company is heading to a major international cancer meeting with new data that goes beyond the disease its treatment is already approved for. The presentations include results in a rare cancer where patients have few options once standard treatment stops working, along with an early look at using the therapy sooner in a more common one. Here’s what the company plans to share and why the lineup is drawing attention. Read More >
What If Type 1 Diabetes Could Be Treated by Shielding the Cells Instead of Replacing the Insulin?
A Radnor-based biotech has dosed the first patient in an early trial of a new approach to type 1 diabetes, one designed to calm the immune attack on insulin-producing cells without switching off the immune system everywhere. The experimental therapy aims to home in on the tissue under attack, with the goal of preserving the body’s own insulin production. Read More >
Ecosystem
The partnerships, programs, and policy moves building Greater Philadelphia’s life sciences infrastructure — and the organizations driving it forward.
Inside the New Lab Where Robots and Real-Time Data Meet Clinical Testing
A global pharma company has opened a new high-tech lab on one of its longest-running campuses in the Philadelphia suburbs. The facility is built around robotics, automation, and real-time data to change how clinical testing is done, and it fits into a broader push to expand the company’s footprint across the region. Here’s what the new lab is designed to do and how it connects to the company’s other projects in the area. Read More >
The Partnership Aiming to Close the Gap Between Research and the Exam Room
A pharma leader and a major technology company have announced plans to team up on a global effort to make clinical trials faster and get patients the right care sooner. The work would focus on finding the right patients for trials, spotting disease earlier, and monitoring drug safety, all using de-identified real-world data. Here’s what the first project looks like and what safeguards the companies say are built in. Read More >
The Free Tool Helping Young Biotechs Keep Their Labs Running
A Bucks County life sciences incubator has added a new strategic sponsor, and the early-stage companies in its community stand to benefit. The sponsor offers a platform for managing lab supplies and inventory, with free access for the smallest startups and discounts for other members. Here’s what the partnership offers and what’s coming up to mark the kickoff. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in PHL biotech and life sciences this week.
BriaCell’s Phase Three Trial Could Change Late Stage Breast Cancer Treatment
In a recent interview, the CEO of a clinical-stage cancer company walks through its pivotal Phase 3 trial in late-stage breast cancer, a study the company says has drawn attention as one to watch this year. He explains what the earlier results showed, how the company’s newer off-the-shelf approach differs from other immunotherapies, and what is still ahead before the trial’s headline data. Here’s what he says could be at stake for patients who’ve run out of options. Watch More >
AI model can uncover unseen health issues in CT scans
A routine CT scan is usually ordered to answer one question, but a new AI model built at a Philadelphia health system suggests it may be holding many more answers. The model learns from a huge archive of patient data and works in the background to flag signs of disease and future health risks that a human reader might miss. It’s still being tested before it reaches the clinic, so here’s what the researchers found and where they hope to take it next. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across Greater Philadelphia’s life sciences ecosystem that you don’t want to miss.
2026 AI & Digital Health Day
Friday, October 23, 2026 • 8 AM–5:30 PM • Princeton, NJ
Hosted by BioNJ | Register Now >
2026 Inspiring Women In STEM Conference
Thursday, October 29, 2026 • 8:30 AM–4:30 PM • Newark, DE
Hosted by DelawareBio | Register Now >
2026 MidAtlantic Bioinformatics Conference
Friday, October 30, 2026 • 8:30 AM–4:30 PM • Philadelphia, PA
Hosted by Children’s Hospital of Philadelphia | Register Now >
Did we miss something!? Drop us a line →
Stay connected to Greater Philadelphia’s life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the Greater Philadelphia Region Roundup every Thursday.
The week’s most important life sciences news from PHL— delivered to your inbox.
